Autoimmunity and autoimmune co-morbidities in psoriasis

Kazuhisa Furue, Takamichi Ito, Gaku Tsuji, Takafumi Kadono, Takeshi Nakahara, Masutaka Furue

研究成果: ジャーナルへの寄稿評論記事

5 引用 (Scopus)

抄録

Psoriasis is characterized by widespread scaly erythematous plaques that cause significant physical and psychological burdens for the affected individuals. Accelerated inflammation driven by the tumour necrosis factor-α/interleukin-23/interleukin-17 axis is now known to be the major mechanism in the development of psoriasis. In addition, psoriasis has an autoimmune nature that manifests as autoreactive T cells and is co-morbid with other autoimmune diseases, such as autoimmune bullous diseases, vitiligo, alopecia and thyroiditis. In this article, we review the recent topics on autoimmunity and autoimmune co-morbidities in psoriasis.

元の言語英語
ページ(範囲)21-27
ページ数7
ジャーナルImmunology
154
発行部数1
DOI
出版物ステータス出版済み - 5 1 2018

Fingerprint

Autoimmunity
Psoriasis
Morbidity
Autoimmune Diseases
Interleukin-23
Thyroiditis
Vitiligo
Interleukin-17
Alopecia
Tumor Necrosis Factor-alpha
Psychology
Inflammation
T-Lymphocytes

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

これを引用

Autoimmunity and autoimmune co-morbidities in psoriasis. / Furue, Kazuhisa; Ito, Takamichi; Tsuji, Gaku; Kadono, Takafumi; Nakahara, Takeshi; Furue, Masutaka.

:: Immunology, 巻 154, 番号 1, 01.05.2018, p. 21-27.

研究成果: ジャーナルへの寄稿評論記事

@article{34648353b4f647919698f016f25e865d,
title = "Autoimmunity and autoimmune co-morbidities in psoriasis",
abstract = "Psoriasis is characterized by widespread scaly erythematous plaques that cause significant physical and psychological burdens for the affected individuals. Accelerated inflammation driven by the tumour necrosis factor-α/interleukin-23/interleukin-17 axis is now known to be the major mechanism in the development of psoriasis. In addition, psoriasis has an autoimmune nature that manifests as autoreactive T cells and is co-morbid with other autoimmune diseases, such as autoimmune bullous diseases, vitiligo, alopecia and thyroiditis. In this article, we review the recent topics on autoimmunity and autoimmune co-morbidities in psoriasis.",
author = "Kazuhisa Furue and Takamichi Ito and Gaku Tsuji and Takafumi Kadono and Takeshi Nakahara and Masutaka Furue",
year = "2018",
month = "5",
day = "1",
doi = "10.1111/imm.12891",
language = "English",
volume = "154",
pages = "21--27",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Autoimmunity and autoimmune co-morbidities in psoriasis

AU - Furue, Kazuhisa

AU - Ito, Takamichi

AU - Tsuji, Gaku

AU - Kadono, Takafumi

AU - Nakahara, Takeshi

AU - Furue, Masutaka

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Psoriasis is characterized by widespread scaly erythematous plaques that cause significant physical and psychological burdens for the affected individuals. Accelerated inflammation driven by the tumour necrosis factor-α/interleukin-23/interleukin-17 axis is now known to be the major mechanism in the development of psoriasis. In addition, psoriasis has an autoimmune nature that manifests as autoreactive T cells and is co-morbid with other autoimmune diseases, such as autoimmune bullous diseases, vitiligo, alopecia and thyroiditis. In this article, we review the recent topics on autoimmunity and autoimmune co-morbidities in psoriasis.

AB - Psoriasis is characterized by widespread scaly erythematous plaques that cause significant physical and psychological burdens for the affected individuals. Accelerated inflammation driven by the tumour necrosis factor-α/interleukin-23/interleukin-17 axis is now known to be the major mechanism in the development of psoriasis. In addition, psoriasis has an autoimmune nature that manifests as autoreactive T cells and is co-morbid with other autoimmune diseases, such as autoimmune bullous diseases, vitiligo, alopecia and thyroiditis. In this article, we review the recent topics on autoimmunity and autoimmune co-morbidities in psoriasis.

UR - http://www.scopus.com/inward/record.url?scp=85041612290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041612290&partnerID=8YFLogxK

U2 - 10.1111/imm.12891

DO - 10.1111/imm.12891

M3 - Review article

C2 - 29315555

AN - SCOPUS:85041612290

VL - 154

SP - 21

EP - 27

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 1

ER -